We’ve published our first Science and Technology Report, providing an overview of Group Research & Development’s current capability and future goals to leverage world-class science in developing and assessing novel technologies with the aim of creating safer tobacco and nicotine products.
This report forms part of our essential approach of openness and transparency on non-competitive science, and we expect its content to both facilitate further dialogue and collaboration on tobacco regulatory science, but also provide non-scientists an insight to our approaches.
An app has now been released with additional multimedia content, including video interviews with some of our key scientists. For iPad, search for BAT R&D in the iTunes store. Other devices can access the report through our web-based app .
Chris Proctor, Chief Scientific Officer, said “Despite massive strides in external acceptance of the role our science can play in underpinning tobacco harm reduction, there remains pressure to prohibit us from contributing, as seen by the recent ban on manuscripts reporting science from tobacco companies introduced by the British Medical Journal. The 2014 Science and Technology Report is unique in that it sets out our ambitions in the non-competitive science of tobacco harm reduction, rather than simply reporting on what we have already done. In doing so, it becomes a call for more collaborative research between all interested parties, in an area of scientific endeavour that could become one of the most important public health initiatives of the 21st Century - tobacco harm reduction.”
- Science and Technology Report 2014 (4,098kb)
Printed copies of the report are available on request, please use the secure enquiries form.
Notes to Editors
About British American Tobacco: British American Tobacco is a global tobacco and Next Generation Product company with brands sold in more than 200 markets. It employs more than 50,000 people worldwide and has over 200 brands in its portfolio, with its cigarettes chosen by one in eight of the world’s one billion smokers. Leading global brands include Dunhill, Kent, Pall Mall and Lucky Strike.
About Next Generation Products (NGP): Next Generation Products is part of the British American Tobacco Group and is focused on developing and delivering high-quality alternative nicotine and tobacco products for adult consumers in the key areas of Vapour, Oral and Tobacco Heating Products. For more information see www.goVype.com and www.bat-science.com.
About Tobacco Harm Reduction: The only way to avoid the risks associated with tobacco use is not to consume tobacco at all, and the best way to reduce the risks is to stop using tobacco. However, the concept of harm reduction is increasingly being considered in relation to tobacco use. Harm reduction is about finding practical ways to minimise the health impact of an inherently risky activity or behaviour, without seeking to stop it entirely. It is a key element of BAT’s business strategy and is being discussed by some regulators. We think it’s important to work towards producing consumer-acceptable, potentially reduced risk products. We believe that tobacco regulatory policies should include harm reduction approaches for the millions of adults globally who will continue to consume tobacco products.
The Public Health Impact of e-cigarettes: Many in the public health community believe e-cigarettes offer great potential for contributing to tobacco harm reduction policies. A 2018 updated evidence review by Public Health England*, an executive body of the UK Department of Health, concludes that vaping is around 95% less harmful than smoking cigarettes. The UK’s Royal College of Physicians have said that the public can be reassured that e-cigarettes are much safer than smoking and that they should be widely promoted as a substitute for smoking.
For more information: email Joanna_Hunt@bat.com or call +44 (0)7858 375461